ClearBridge Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-44,231
| Closed | -$341K | – | 1135 |
|
2019
Q2 | $341K | Sell |
44,231
-318
| -0.7% | -$2.45K | ﹤0.01% | 716 |
|
2019
Q1 | $887K | Buy |
44,549
+258
| +0.6% | +$5.14K | ﹤0.01% | 685 |
|
2018
Q4 | $585K | Sell |
44,291
-43
| -0.1% | -$568 | ﹤0.01% | 714 |
|
2018
Q3 | $1.63M | Buy |
44,334
+20
| +0% | +$735 | ﹤0.01% | 696 |
|
2018
Q2 | $1.55M | Sell |
44,314
-456
| -1% | -$16K | ﹤0.01% | 619 |
|
2018
Q1 | $2.08M | Buy |
44,770
+8
| +0% | +$372 | ﹤0.01% | 579 |
|
2017
Q4 | $1.68M | Buy |
44,762
+45
| +0.1% | +$1.69K | ﹤0.01% | 604 |
|
2017
Q3 | $2.38M | Sell |
44,717
-103
| -0.2% | -$5.48K | ﹤0.01% | 575 |
|
2017
Q2 | $2.56M | Buy |
44,820
+292
| +0.7% | +$16.6K | ﹤0.01% | 563 |
|
2017
Q1 | $2.39M | Buy |
44,528
+2
| +0% | +$107 | ﹤0.01% | 593 |
|
2016
Q4 | $2.54M | Buy |
44,526
+4
| +0% | +$228 | ﹤0.01% | 596 |
|
2016
Q3 | $2.77M | Sell |
44,522
-114
| -0.3% | -$7.09K | ﹤0.01% | 589 |
|
2016
Q2 | $2.52M | Buy |
44,636
+5
| +0% | +$283 | ﹤0.01% | 614 |
|
2016
Q1 | $2.86M | Buy |
44,631
+7
| +0% | +$448 | ﹤0.01% | 594 |
|
2015
Q4 | $6.28M | Sell |
44,624
-7
| -0% | -$985 | 0.01% | 526 |
|
2015
Q3 | $4.32M | Buy |
44,631
+14
| +0% | +$1.36K | 0.01% | 585 |
|
2015
Q2 | $6.77M | Buy |
+44,617
| New | +$6.77M | 0.01% | 537 |
|